Mantle cell lymphoma (MCL) is a subtype of non-Hodgkin lymphoma characterized by the proliferation of B-cells in the mantle zone of lymphoid follicles. It primarily affects lymph nodes in the head, face, and neck, leading to significant clinical manifestations. Accurate coding with ICD-10 Code C83.11 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat this aggressive malignancy.
ICD-10 Code C83.11 specifically identifies mantle cell lymphoma affecting the lymph nodes of the head, face, and neck. This code is utilized when documenting cases of MCL, which is known for its aggressive nature and potential for widespread dissemination. It should be used in clinical documentation and billing when a patient presents with symptoms indicative of this condition, ensuring accurate representation of the diagnosis for treatment and reimbursement purposes.
Mantle cell lymphoma is a hematological malignancy arising from B-lymphocytes, often presenting with lymphadenopathy in the head, face, and neck regions. The etiology involves chromosomal translocations, particularly t(11;14), leading to overexpression of cyclin D1. Early diagnosis and intervention are critical due to its aggressive behavior and poor prognosis.
ICD-10 Code C83.11 is integral in SOAP notes for documenting the clinical presentation, assessment, and treatment of mantle cell lymphoma. It aids in capturing the patient's symptoms, guiding clinical decision-making, and ensuring appropriate management in both acute and chronic care settings.
In SOAP notes, ICD-10 Code C83.11 connects subjective patient-reported symptoms with objective clinical findings, facilitating a formal diagnosis of mantle cell lymphoma. This code is crucial for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Prompt treatment for mantle cell lymphoma is essential due to its aggressive nature. Management typically involves chemotherapy, targeted therapy, and sometimes stem cell transplantation.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C83.11 is critical for accurate billing in hospital, ER, or infectious disease care settings.
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push technique. |
| 85025 | Complete blood count with automated differential. |
| 99214 | Established patient office visit, moderate complexity. |
Common Questions About Using ICD-10 Code C83.11 for Mantle cell lymphoma, lymph nodes of head, face, and neck
What are the common symptoms of mantle cell lymphoma?
Common symptoms include painless swelling of lymph nodes, fever, night sweats, and unexplained weight loss. Patients may also experience fatigue and abdominal discomfort if gastrointestinal involvement occurs.
How is mantle cell lymphoma diagnosed?
Diagnosis typically involves a combination of physical examination, imaging studies, and biopsy of affected lymph nodes. Immunophenotyping and genetic testing may also be performed to confirm the diagnosis.
What treatment options are available for mantle cell lymphoma?
Treatment options include chemotherapy regimens such as R-CHOP, targeted therapies like ibrutinib, and stem cell transplantation for eligible patients. Supportive care is also essential to manage symptoms and complications.
Is mantle cell lymphoma curable?
Mantle cell lymphoma is generally considered an aggressive form of lymphoma with a poor prognosis. While some patients may achieve remission, it is often challenging to cure, and ongoing management is typically required.
Clinical Notes
SOAP notes
DAP notes
AI medical notes